Orchestra BioMed Holdings, Inc. OBIO
6.97 USD -0.15 (-2.11%)
Regular-session close
6.99 +0.02 +0.29%
After hours · Nov 17, 5:09 PM ET
6.95 Day range 7.37
3.46 52-week range 7.45
- YTD
- +67.95%
- 1 year
- +68.77%
OBIO revenue history
Revenue is income from the company’s ordinary business activities.
33,482,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 33,482,000 | 30,844,000 | 1169.22% |
| FY 2024 | 2024-12-31 | 2,638,000 | -122,000 | -4.42% |
| FY 2023 | 2023-12-31 | 2,760,000 | -773,000 | -21.88% |
| FY 2022 | 2022-12-31 | 3,533,000 | 4,315,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -782,000 | -6,485,000 | -113.71% |
| FY 2020 | 2020-12-31 | 5,703,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:36.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
